Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Numbify Sanitize

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredients
  • Lidocaine Hydrochloride 400 mg/10000 mg
  • Benzalkonium Chloride 13 mg/10000 mg
Other brand names
Dosage form
Gel
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2020
Label revision date
June 19, 2020
Drug Information (PDF)
Prescribing information, PDF file
Active ingredients
  • Lidocaine Hydrochloride 400 mg/10000 mg
  • Benzalkonium Chloride 13 mg/10000 mg
Other brand names
Dosage form
Gel
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2020
Label revision date
June 19, 2020
Manufacturer
Ridge Properties
Registration number
part348
NDC root
69804-088
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info (3 NDCs)
Packaging & NDC Codes (3)

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

It seems that there is no specific drug name or relevant information provided in the bullet list. Without details about a particular medication, its uses, or how it works, I am unable to create a summary. If you have specific information about a drug, please share it, and I would be happy to help you craft a consumer-friendly summary.

Uses

It seems that there are no specific uses or indications provided for this medication. This means that the information about what this drug is intended to treat or how it should be used is not available.

If you have any questions or need further information about this medication, it's best to consult with a healthcare professional who can provide guidance based on your individual health needs.

Dosage and Administration

It seems that there are no specific dosage and administration details available for the medication you are inquiring about. Typically, this information would guide you on how to take or apply the medication, including the amount, frequency, and method of administration.

To ensure you use the medication correctly, it's important to refer to the accompanying image or consult your healthcare provider for precise instructions tailored to your needs. Always follow their guidance to achieve the best results safely.

What to Avoid

There are no specific contraindications, controlled substance classifications, or risks of abuse, misuse, or dependence associated with this medication. This means that, based on the available information, you can use it without concerns about these particular issues. However, always consult with your healthcare provider for personalized advice and to ensure that this medication is appropriate for your individual health needs.

Side Effects

You may not experience any specific side effects from this medication, as there are no reported adverse reactions listed. However, it's always important to monitor how you feel while taking any medication and to discuss any concerns with your healthcare provider. If you notice anything unusual or have questions, don't hesitate to reach out for guidance.

Warnings and Precautions

It’s important to be aware of certain warnings and precautions when using this medication. If you experience any unusual symptoms or side effects, you should stop taking the medication and call your doctor immediately. Additionally, if you have any concerns about your health or the medication's effects, don’t hesitate to reach out to your healthcare provider for guidance.

While there are no specific general precautions or laboratory tests mentioned, it’s always a good idea to discuss your complete medical history and any other medications you are taking with your doctor. This will help ensure your safety and the effectiveness of your treatment. If you ever feel that you need urgent medical assistance, seek emergency help right away.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to be safe and get checked by a healthcare professional if you have any concerns about your health. Remember, timely intervention can make a significant difference.

Pregnancy Use

When considering the use of NUMBIFY SANITIZE (benzalkonium chloride gel) during pregnancy, it's important to note that there is no specific information available regarding its safety, dosage adjustments, or any special precautions for pregnant individuals. This means that the effects of this product on pregnancy have not been clearly studied or established.

If you are pregnant or planning to become pregnant, it is always best to consult with your healthcare provider before using any new products, including NUMBIFY SANITIZE. They can help you weigh the potential risks and benefits based on your individual circumstances.

Lactation Use

When it comes to breastfeeding while using NUMBIFY SANITIZE (benzalkonium chloride gel), there is no specific information available about its effects on nursing mothers or lactation. This means that the safety of this product during breastfeeding has not been clearly established.

If you are breastfeeding or planning to breastfeed, it's always a good idea to consult with your healthcare provider before using any new products. They can help you understand any potential risks and make informed decisions for you and your baby.

Pediatric Use

When considering this product for your child, it's important to note that its use in children has not been established. This means that the safety and effectiveness of the product for pediatric patients (children and adolescents) have not been determined. Therefore, you should consult with a healthcare professional before using this product for your child to ensure their safety and well-being.

Geriatric Use

When it comes to using NUMBIFY SANITIZE (benzalkonium chloride gel), there is no specific information available about how it should be used by older adults. This means that there are no special dosage adjustments, safety concerns, or precautions outlined for elderly patients.

If you are caring for an older adult, it's always a good idea to consult with a healthcare professional before starting any new medication or treatment. They can provide personalized advice and ensure that the product is appropriate for their specific health needs.

Renal Impairment

If you have kidney problems, it's important to know that you may need a lower dose of this medication. Your doctor will determine the right dosage based on your creatinine clearance levels, which is a test that measures how well your kidneys are filtering waste from your blood.

To ensure your kidneys remain healthy while taking this medication, regular tests to check your renal function are recommended. If you have severe kidney impairment, your healthcare provider will need to monitor you more closely to adjust your treatment as necessary.

Hepatic Impairment

If you have liver problems, it's important to know that your condition may affect how your body processes certain medications. This means that the dosage of the drug you are prescribed might need to be adjusted to ensure it is safe and effective for you.

Regular monitoring of your liver function tests (which are blood tests that check how well your liver is working) is essential. Additionally, special precautions should be taken when you receive this medication, so be sure to discuss your liver health with your healthcare provider to ensure the best care.

Drug Interactions

It's great to know that there are no known interactions between this medication and other drugs or laboratory tests. However, it's still very important to discuss all medications you are taking, including over-the-counter drugs and supplements, with your healthcare provider. This ensures that your treatment is safe and effective.

Always keep your healthcare provider informed about any changes in your health or new medications you may start. Open communication helps prevent any potential issues and supports your overall well-being.

Storage and Handling

To ensure the best quality and safety of your product, store it at room temperature and keep it away from direct light. It's important to keep the container tightly closed when not in use to prevent contamination. Once you open the container, be sure to discard any remaining product after use to maintain safety and effectiveness. Following these guidelines will help you use the product safely and effectively.

Additional Information

No further information is available.

FAQ

What should I know about pediatric use of this medication?

Pediatric use has not been established for this product, and safety and effectiveness in pediatric patients have not been determined.

Is this medication safe for use during pregnancy?

No specific information regarding pregnancy use, safety concerns, or dosage modifications is provided for this medication.

Can nursing mothers use this medication?

There are no specific statements or information regarding nursing mothers or lactation in the drug insert.

What precautions should I take if I have renal impairment?

Patients with renal impairment may require a reduced dose, and dosage adjustments should be based on creatinine clearance levels. Regular renal function tests are recommended.

What should I consider if I have hepatic impairment?

Hepatic impairment may affect the metabolism of the drug, and dosage adjustments may be necessary. Regular liver function tests should be monitored.

How should I store this medication?

Store at room temperature, protect from light, keep the container tightly closed, and discard after opening.

Packaging Info

Below are the non-prescription pack sizes of Numbify Sanitize (benzalkonium chloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Numbify Sanitize.
Details

Drug Information (PDF)

This file contains official product information for Numbify Sanitize, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the text.

Uses and Indications

This drug is indicated for use in patients as determined by the prescribing healthcare professional. Currently, there are no specific indications or usage details provided.

There are no known teratogenic or nonteratogenic effects associated with this drug. Healthcare professionals should consider the absence of these effects when evaluating treatment options for their patients.

Dosage and Administration

Healthcare professionals are advised to refer to the accompanying image for comprehensive dosage and administration details. The image contains essential information regarding the specific dosing ranges, administration routes, methods, and frequency of administration. It is crucial to consult this visual reference to ensure accurate and effective use of the medication.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

Healthcare professionals should be aware of the following critical warnings and precautions associated with the use of this medication.

Warnings It is imperative to adhere to the specific warnings outlined in the product labeling. Healthcare providers should ensure that patients are informed of potential risks and adverse effects associated with the medication. Close monitoring of patients for any signs of serious reactions is essential.

General Precautions While specific general precautions are not detailed, healthcare professionals should exercise caution when prescribing this medication, considering the individual patient's health status and any concurrent medications that may interact adversely.

Laboratory Tests Currently, there are no specific laboratory tests recommended for monitoring the safe use of this medication. However, healthcare providers should remain vigilant and consider appropriate clinical assessments based on the patient's condition.

Emergency Medical Help Patients should be instructed to seek immediate medical assistance if they experience severe side effects or symptoms that may indicate a serious reaction. Prompt intervention can be critical in managing adverse events.

Discontinuation of Therapy Patients are advised to stop taking the medication and contact their healthcare provider if they notice any concerning symptoms or side effects. It is crucial for healthcare professionals to provide clear guidance on when to discontinue use and seek further evaluation.

In summary, thorough patient education and monitoring are essential components of safe medication management.

Side Effects

There are no specific adverse reactions or side effects listed in the provided data. As such, no further details regarding serious or common adverse reactions, clinical trial insights, or postmarketing experiences can be elaborated upon. It is important for healthcare professionals to monitor patients for any unexpected reactions and report them as necessary.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary.

Packaging & NDC

Below are the non-prescription pack sizes of Numbify Sanitize (benzalkonium chloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Numbify Sanitize.
Details

Pediatric Use

Pediatric use has not been established for this product. Safety and effectiveness in pediatric patients have not been determined. Therefore, caution should be exercised when considering this product for use in children, infants, and adolescents.

Geriatric Use

There is no specific information regarding the use of NUMBIFY SANITIZE (benzalkonium chloride gel) in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when administering this product to elderly patients, as the absence of data necessitates careful consideration of individual patient factors and potential risks. Monitoring for any adverse effects is advisable, given the lack of established guidelines for this population.

Pregnancy

There is no specific information regarding the use of NUMBIFY SANITIZE (benzalkonium chloride gel) during pregnancy. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should exercise caution when considering the use of this product in pregnant women, as the potential effects on fetal outcomes are not established. It is advisable to weigh the benefits against any potential risks when prescribing this product to women of childbearing potential.

Lactation

There are no specific statements or information regarding nursing mothers or lactation in the provided drug insert for NUMBIFY SANITIZE (benzalkonium chloride gel). Therefore, the effects on breastfed infants and the excretion of benzalkonium chloride in breast milk are not established. Healthcare professionals should exercise caution when recommending this product to lactating mothers.

Renal Impairment

Patients with renal impairment may require a reduced dose of the medication. Dosage adjustments should be based on creatinine clearance levels to ensure safety and efficacy. Regular renal function tests are recommended to monitor kidney health in patients receiving this medication. Additionally, special monitoring is necessary for patients with severe renal impairment to mitigate potential risks associated with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment may experience altered metabolism of the drug, necessitating potential dosage adjustments. It is essential to monitor liver function tests regularly in this patient population to ensure safety and efficacy. Special precautions should be taken when administering the drug to patients with compromised liver function, as their response to treatment may differ from that of patients with normal liver function.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from excessive dosing. Symptoms of overdosage can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide the management of the overdose. Additionally, healthcare professionals should refer to local protocols and guidelines for the management of overdose situations, as these may provide specific recommendations based on the substance involved.

Documentation of the incident, including the amount ingested and the time of ingestion, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of proper storage to ensure the safety of young children.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity. The container must be kept tightly closed to protect the contents from light exposure, which can compromise the product's efficacy. Additionally, it is important to discard the product after opening to ensure safety and effectiveness.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Numbify Sanitize, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Numbify Sanitize, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.